Literature DB >> 18923166

Recurrence of hepatocellular carcinoma.

Morris Sherman.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18923166     DOI： 10.1056/NEJMe0807581

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  82 in total

1.  Function and clinical potential of microRNAs in hepatocellular carcinoma.

Authors:  Lijuan Wang; Yongfang Yue; Xian Wang; Hongchuan Jin
Journal:  Oncol Lett       Date:  2015-09-29       Impact factor: 2.967

2.  A standardized pathological proposal for evaluating microvascular invasion of hepatocellular carcinoma: a multicenter study by LCPGC.

Authors:  Xia Sheng; Yuan Ji; Guo-Ping Ren; Chang-Li Lu; Jing-Ping Yun; Li-Hong Chen; Bin Meng; Li-Juan Qu; Guang-Jie Duan; Qing Sun; Xin-Qing Ye; Shan-Shan Li; Jing Yang; Bing Liao; Zhan-Bo Wang; Jian-Hua Zhou; Yu Sun; Xue-Shan Qiu; Lei Wang; Zeng-Shan Li; Jun Chen; Chun-Yan Xia; Song He; Chuan-Ying Li; En-Wei Xu; Jing-Shu Geng; Chao Pan; Dong Kuang; Rong Qin; Hong-Wei Guan; Zhan-Dong Wang; Li-Xing Li; Xi Zhang; Han Wang; Qian Zhao; Bo Wei; Wu-Jian Zhang; Shao-Ping Ling; Xiang Du; Wen-Ming Cong
Journal:  Hepatol Int       Date:  2020-12-28       Impact factor: 6.047

Review 3.  Molecular classification and novel targets in hepatocellular carcinoma: recent advancements.

Authors:  Yujin Hoshida; Sara Toffanin; Anja Lachenmayer; Augusto Villanueva; Beatriz Minguez; Josep M Llovet
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

Review 4.  Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges.

Authors:  Yujin Hoshida; Bryan C Fuchs; Kenneth K Tanabe
Journal:  Curr Cancer Drug Targets       Date:  2012-11-01       Impact factor: 3.428

5.  Validation of ORAOV1 as a new treatment target in hepatocellular carcinoma.

Authors:  Sang Yun Ha; So-Young Yeo; Keun-Woo Lee; Seok-Hyung Kim
Journal:  J Cancer Res Clin Oncol       Date:  2020-11-08       Impact factor: 4.553

6.  Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival.

Authors:  Stephanie Roessler; Ezhou Lori Long; Anuradha Budhu; Yidong Chen; Xuelian Zhao; Junfang Ji; Robert Walker; Hu-Liang Jia; Qing-Hai Ye; Lun-Xiu Qin; Zhao-You Tang; Ping He; Kent W Hunter; Snorri S Thorgeirsson; Paul S Meltzer; Xin Wei Wang
Journal:  Gastroenterology       Date:  2011-12-24       Impact factor: 22.682

7.  Molecular profiling to predict hepatocellular carcinoma outcome.

Authors:  Yujin Hoshida; Augusto Villanueva; Josep M Llovet
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 3.869

Review 8.  Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.

Authors:  Virginia Hernandez-Gea; Sara Toffanin; Scott L Friedman; Josep M Llovet
Journal:  Gastroenterology       Date:  2013-01-09       Impact factor: 22.682

Review 9.  Hepatocellular carcinoma--resection or transplant?

Authors:  Sheung Tat Fan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-09-11       Impact factor: 46.802

10.  Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis.

Authors:  Yujin Hoshida; Augusto Villanueva; Angelo Sangiovanni; Manel Sole; Chin Hur; Karin L Andersson; Raymond T Chung; Joshua Gould; Kensuke Kojima; Supriya Gupta; Bradley Taylor; Andrew Crenshaw; Stacey Gabriel; Beatriz Minguez; Massimo Iavarone; Scott L Friedman; Massimo Colombo; Josep M Llovet; Todd R Golub
Journal:  Gastroenterology       Date:  2013-01-17       Impact factor: 22.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.